Recent studies reveal the potential of RMP1-14, a recently developed anti-mouse PD-1 reagent , for improving cancer treatment. Unlike current approaches, RMP1-14 exhibits superior affinity to murine PD-1, https://cecilyltgd398773.wikiexpression.com/6382820/employing_rmp1_14_an_novel_anti_mouse_pd1_agent_in_immune_therapy